https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Analysis of genotyping methodologies to detect RAS mutations

2 de March de 2020

It is currently known that those patients with metastatic colorectal cancer (CCRm) whose tumors have mutations at the level of certain genes involved in the EGFR receptor pathway (HER-1), such as the RAS gene (KRAS or NRAS exons 2,3 and 4 ), do not benefit from therapy with monoclonal antibodies with antiEGFR activity (Cetuximab or […]

Read more →

Conference on Hepatocarcinoma Multidisciplinary approach in 2020

24 de February de 2020

Hepatocarcinoma is a challenge in all aspects such as diagnosis, staging or selection of the best treatment for each patient. In a few disorders like this one and in all the phases of their attention, the collaboration of several specialties is necessary. Therefore, and with the double objective of updating the latest technical knowledge and […]

Read more →

Diagnostic value of bone marrow biopsy in patients with lymphoplasmacytic B lymphoma

The article “Diagnostic value of Bone marrow core biopsy patterns in Lymphoplasmacytic Lymphoma / Waldeström Macroglobulinemia and description of its mutational profiles by targeted NGS” has recently been published in the international Journal of Clinical Pathology (FI 2,346, JCR). This original manuscript describes the clinical relevance of the evaluation by multiparameter methods (morphology and histopathology, […]

Read more →

Leonado-BBVA Foundation Scholarships

21 de February de 2020

The Leonardo Scholarships for Researchers and Cultural Creators granted by the BBVA Foundation are intended to directly support the work of researchers and cultural creators between 30 and 45 years of age who, being in the middle stages of their career, develop a markedly personal and innovative project in the corresponding area of specialization or […]

Read more →

Next Santander Biomedical Lectures conference

20 de February de 2020

Next Thursday, February 27, the next conference of the fourth edition of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and the IBBTEC given by Dr. Martin will be held with the title “MTBVAC a new vaccine against tuberculosis, from laboratory to clinical trials of efficacy in endemic countries ”. Carlos […]

Read more →

2 units of IDIVAL and 18 of Valdecilla with ISO quality certifications

The User Care, Immunology and Radiodiagnostic Services of the Marqués de Valdecilla University Hospital have received the ISO 9001: 2015 accreditation, which certifies their commitment to quality and safety in the framework of continuous improvement to achieve the best health results. With these three new accreditations, Valdecilla brings to 20 the number of services and […]

Read more →

Nonpharmacological treatments in Parkinsons disease

19 de February de 2020

The study “Nonpharmacological, nonsurgical treatments for freezing of gait in Parkinson's disease: A systematic review” published in the journal Movement Disorders, has been led by Manuel Delgado, Neurologist of the Sierrallana Hospital and researcher of the Area of Psychiatry of IDIVAL and has had the participation of other experts in disorders of the movement of […]

Read more →

Call for the selection of scientific director of IDIVAL

18 de February de 2020

On February 14, the Call for Official Selection of the Scientific Director of the Marqués de Valdecilla Research Institute Foundation (IDIVAL) has been published in the Official Gazette of Cantabria. The functions of the Scientific Director are contemplated in article 35 of the founding Statutes (link to the Statutes of IDIVAL) Applicants who meet the […]

Read more →

Proposed provisional resolution for UC-IDIVAL call concession

Proposal for a provisional resolution to grant the 2019 call for grants for predoctoral contracts of the Research Personnel Program in Predoctoral Training in the area of biomedicine, biotechnology and health sciences, published by resolution of the Director of Management of the Marquis Research Institute of Valdecilla (IDIVAL) and the Vice Chancellor for Research and […]

Read more →

Caixaimpulse call for valuation and commercialization plans

13 de February de 2020

The CaixaImpulse Call is intended for the financing of projects focused on the valuation and commercialization of the protected or susceptible assets protected by the investigation. Projects must be related to the fields of life sciences, medical sciences and health sciences, specifically in the following fields: Life sciences: biomathematics, cell biology, human biology, biochemistry and […]

Read more →